News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Generic Drug Maker Fails In Effort Against Procter & Gamble
July 6, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
A company that sells a generic version of a drug made by Procter & Gamble Co. lost its appeal to prevent the consumer products maker from marketing a separate form of the medication through a licensee.
Twitter
LinkedIn
Facebook
Email
Print
Legal
MORE ON THIS TOPIC
China
US ‘eroding’ lead in rare diseases a matter of national security: Report
July 22, 2026
·
4 min read
·
Tristan Manalac
Manufacturing
FDA’s first AI-focused cGMP warning letter signals new scrutiny for manufacturers
July 16, 2026
·
3 min read
·
John Potter
Psychedelics
Final psychedelics guidance suggests FDA is ‘receptive’ to helping companies succeed
July 14, 2026
·
3 min read
·
Michael Gibney
Manufacturing
FDA proposes streamlined requirements for ‘hub-and-spoke’ manufacturing models
July 14, 2026
·
2 min read
·
Nick Paul Taylor
